Benzene

Benzene

SCHEMBL7967225

NCCN.c1ccccc1

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Benzene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.42
HTR2A P28223 3/20 0.41
LOXL2 Q9Y4K0 2/20 0.41
CYP2A6 P11509 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TSHR P16473 2/20 0.38
TP53 P04637 1/20 0.38
HRH1 P35367 1/20 0.37
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 1/20 0.36
TRPM2 O94759 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
THRB P10828 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
ALOX12 P18054 1/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL28116921 0.94 TAAR1 (0.40) TAAR1HTR2ALOXL2CYP2A6SMN1; SMN2
Benzene SCHEMBL27687179 0.94 TAAR1 (0.40) TAAR1HTR2ALOXL2CYP2A6SMN1; SMN2
Benzene SCHEMBL28095018 0.80
Ethylenediamine SCHEMBL28924405 0.79 NFKB1 (0.50) TSHRTP53MEN1ALDH1A1CYP1A2
Ethylenediamine SCHEMBL30253568 0.79
Ethylenediamine SCHEMBL3083 0.79
Ethylenediamine SCHEMBL7085968 0.79 NFKB1 (0.50) TSHRTP53MEN1ALDH1A1CYP1A2
Ethylenediamine SCHEMBL37647 0.79
Ethylenediamine SCHEMBL23633140 0.72
Ethylenediamine SCHEMBL371485 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107096401-A A kind of high-k Nano filtering composite membrane and preparation method thereof 内蒙古天环境技术有限公司 2017-08-29 CN claimed
CN-103977718-B Positive osmosis composite membrane of a kind of high water flux and preparation method thereof UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA (CN) 2016-03-02 CN claimed
CN-105289322-A Composite forward osmosis membrane based on superthin support layer and preparation method thereof UNIV TIANJIN POLYTECHNIC 2016-02-03 CN claimed
EP-2486975-B1 FAST MIXING REACTOR AND USE THEREOF WANHUA CHEMICAL GROUP CO LTD (CN) 2015-09-23 EP claimed
US-9138717-B2 High-speed mixing reactor and application thereof WANHUA CHEMICAL GROUP CO., LTD (CN) 2015-09-22 US claimed
CN-103977718-A High-water-flux forward-osmosis composite membrane and preparation method thereof USTC UNIV SCIENCE TECH CN 2014-08-13 CN claimed
US-20130178596-A1 HIGH-SPEED MIXING REACTOR AND APPLICATION THEREOF YANTAI WANHUA POLYURETHANES CO., LTD. (CN) 2013-07-11 US claimed
EP-2486975-A1 FAST MIXING REACTOR AND USE THEREOF Yantai Wanhua Polyurethanes Co., Ltd. (CN) 2012-08-15 EP claimed
CN-117567390-A Benzene-1, 2-ethylenediamine compound containing (1, 3, 4-thiadiazole) and preparation method and application thereof 中国海洋大学 2024-02-20 CN disclosed
CN-117567390-A Benzene-1, 2-ethylenediamine compound containing (1, 3, 4-thiadiazole) and preparation method and application thereof 中国海洋大学 2024-02-20 CN disclosed
CN-117567390-A Benzene-1, 2-ethylenediamine compound containing (1, 3, 4-thiadiazole) and preparation method and application thereof 中国海洋大学 2024-02-20 CN disclosed
CN-107428664-B Method for producing (meth) acrylate compound 株式会社可乐丽 2020-07-10 CN disclosed
CN-110386893-A Isoindole derivatives 天津合美医药科技有限公司 2019-10-29 CN disclosed
CN-108578380-A Controlled releasing penetrant pump 广州玻思韬控释药业有限公司 2018-09-28 CN disclosed
CN-1997371-A Nicotinamide derivatives and their use as therapeutic agents XENON PHARMACEUTICALS INC (CA) 2007-07-11 CN disclosed
US-6329523-B1 FOR ANTIBACTERIAL PHARMACEUTICAL USE, USEFUL FOR IDENTIFYING METAL CHELATING SPECIES FOR ?HEAVY METAL? THERAPY; IMAGING AGENTS ISIS PHARMACEUTICALS, INC. 2001-12-11 US disclosed
WO-1998005961-A1 COMPOUNDS HAVING A PLURALITY OF NITROGENOUS SUBSTITUENTS ISIS PHARMACEUTICALS, INC. (US) 1998-02-12 WO disclosed
EP-0347435-A4 DNA SEQUENCES, RECOMBINANT DNA MOLECULES AND PROCESSES FOR PRODUCING SOLUBLE T4 PROTEINS 1991-11-21 EP disclosed
EP-0347435-A1 DNA SEQUENCES, RECOMBINANT DNA MOLECULES AND PROCESSES FOR PRODUCING SOLUBLE T4 PROTEINS BIOGEN, INC. (US) 1989-12-27 EP disclosed
WO-1989001940-A1 DNA SEQUENCES, RECOMBINANT DNA MOLECULES AND PROCESSES FOR PRODUCING SOLUBLE T4 PROTEINS BIOGEN, INC. (US) 1989-03-09 WO disclosed